What are the major opportunities in the Tardive Dyskinesia Therapeutics market? What are the strategies for the Tardive Dyskinesia Therapeutics market?

For detailed insights on the major opportunities and strategies in the Tardive Dyskinesia Therapeutics market, Read More

How does the Tardive Dyskinesia Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Tardive Dyskinesia Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Tardive Dyskinesia Therapeutics market growth? SWOT analysis of the Tardive Dyskinesia Therapeutics market.

For detailed insights on the key dynamics influencing the Tardive Dyskinesia Therapeutics market growth and SWOT analysis of the Tardive Dyskinesia Therapeutics industry, Read More

Tardive Dyskinesia Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Tardive Dyskinesia Therapeutics Market Report 2026

Name: Tardive Dyskinesia Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug (Deutetrabenazine, Valbenazine, Other Drugs), By Product Type (Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form), By Application (Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia), By End-User (Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Tardive Dyskinesia Therapeutics Market Overview

• Tardive Dyskinesia Therapeutics market size has reached to $3.12 billion in 2025

• Expected to grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Rising Mental Health Disorders Driving The Growth Of The Market Due To Increasing Use Of Long-Term Antipsychotics

• Market Trend: Advancements In Once-Daily Treatment Options Enhancing Consistent Drug Delivery And Patient Compliance

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tardive Dyskinesia Therapeutics Market?

Tardive dyskinesia therapeutics involve treatments designed to reduce or manage the uncontrollable, repetitive movements associated with this neurological disorder. These therapies are developed to target the underlying neurological imbalances often associated with prolonged use of certain medications. The goal is to improve patient quality of life by reducing the severity and frequency of motor disturbances, restoring functional abilities, and minimizing long-term complications.

The main drugs of tardive dyskinesia therapeutics are deutetrabenazine, valbenazine, and others. Deutetrabenazine is a vesicular monoamine transporter type 2 (VMAT2) inhibitor used as a medication to manage involuntary movements associated with tardive dyskinesia. It offers various product types including solid dosage forms, tablets, capsules, liquid dosage form, and injection and is applied for antipsychotic-induced tardive dyskinesia, other drug-induced tardive dyskinesia, and idiopathic tardive dyskinesia. It is used by several end-users such as hospitals, clinics, specialty treatment centers, and homecare settings.

Tardive Dyskinesia Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Tardive Dyskinesia Therapeutics Market Size and Share 2026?

The tardive dyskinesia therapeutics market size has grown strongly in recent years. It will grow from $3.12 billion in 2025 to $3.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to limited treatment options for tardive dyskinesia, reliance on conventional antipsychotic management, low patient awareness, growing prevalence of antipsychotic use, restricted specialty treatment centers.

What Is The Tardive Dyskinesia Therapeutics Market Growth Forecast?

The tardive dyskinesia therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to development of novel therapeutics for tardive dyskinesia, increased r&d investment in neurological disorders, rising preference for homecare settings, expansion of specialty treatment centers, enhanced patient monitoring and digital therapeutics. Major trends in the forecast period include rising adoption of deutetrabenazine and valbenazine, increased focus on personalized neurological therapy, expansion of homecare and remote treatment options, growing awareness about drug-induced tardive dyskinesia, emphasis on safety and compliance in long-term treatment.

Book your 30 minutes free consultation with our research experts

Global Tardive Dyskinesia Therapeutics Market Segmentation

1) By Drug: Deutetrabenazine, Valbenazine, Other Drugs

2) By Product Type: Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form

3) By Application: Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia

4) By End-User: Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings

Subsegments:

1) By Deutetrabenazine: Dosage Forms, Line Of Therapy, Distribution Channel

2) By Valbenazine: Dosage Forms, Patient Age Group, Distribution Channel

3) By Other Drugs: Drug Class Or Type, Dosage Forms, Treatment Duration

What Is The Driver Of The Tardive Dyskinesia Therapeutics Market?

The increasing prevalence of mental health disorders is expected to propel the growth of the tardive dyskinesia therapeutics market going forward. Mental health disorders are conditions that affect a person’s thoughts, emotions, behavior, or functioning, often causing significant distress or difficulty in daily life. Mental health disorders are rising due to increasing social isolation, as the shift toward digital communication and fast-paced lifestyles has reduced meaningful in-person connections, resulting to greater feelings of loneliness and emotional strain. Tardive dyskinesia therapeutics support mental disorder patients by managing involuntary movement symptoms caused by long-term antipsychotic use, thereby improving treatment adherence and overall quality of life. For instance, in 2024, according to the National Alliance On Mental Illness, a US-based organization, among people in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations each year. Therefore, the increasing prevalence of mental health disorders drives the tardive dyskinesia therapeutics industry.

Key Players In The Global Tardive Dyskinesia Therapeutics Market

Major companies operating in the tardive dyskinesia therapeutics market are Neurocrine Biosciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation, AbbVie Inc., Pfizer Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Ltd., Lupin Limited, Amneal Pharmaceuticals Inc., Lannett Company Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Accord Healthcare Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Indivior PLC, Viatris Inc., Alkem Laboratories Ltd., Intas Pharmaceuticals Ltd., Som Biotech Ltd., Addex Therapeutics Ltd., Luye Pharma Group Ltd., Apotex Inc., Sandoz Group AG, Torrent Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Taro Pharmaceutical Industries Ltd., Cadila Pharmaceuticals Ltd.

Global Tardive Dyskinesia Therapeutics Market Trends and Insights

Major companies operating in the tardive dyskinesia therapeutics market are focusing on developing advanced products, such as once-daily treatment options, to help maintain more consistent drug levels in the body. Once-daily treatment options refer to medications or therapies that are designed to be taken just once per day, simplifying dosing schedules and improving patient adherence. For instance, in May 2024, Teva Pharmaceutical Industries Limited, an Israel-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for AUSTEDO XR tablets for treating adults with tardive dyskinesia (TD) and Huntington’s disease (HD) chorea. The recent approval of AUSTEDO XR offers patients proven effectiveness in managing involuntary movements with the added convenience of a once-daily, single-pill dosage. This new formulation delivers clinically therapeutic doses confirmed by pivotal clinical trials. Additionally, it is now available in four different tablet strengths: 30 mg, 36 mg, 42 mg, and 48 mg.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Tardive Dyskinesia Therapeutics Market?

In February 2024, Teva Pharmaceutical Industries Limited, an Israel-based biopharmaceutical company, partnered with Jiangsu Nhwa Pharmaceutical Co. Ltd. in order to promote and distribute Teva's AUSTEDO. The collaboration aims to expand patient access to Teva’s AUSTEDO by utilizing Nhwa’s strong presence in China’s neuropsychiatric health market. AUSTEDO is recognized as the first VMAT2 inhibitor approved by the U.S. FDA for treating tardive dyskinesia and chorea linked to Huntington’s disease in adults. Jiangsu Nhwa Pharmaceutical Co. Ltd. is a China-based pharmaceutical company.

Regional Insights

North America was the largest region in the tardive dyskinesia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tardive Dyskinesia Therapeutics Market?

The tardive dyskinesia therapeutics market consists of revenues earned by entities by providing services such as drug discovery, clinical trial management, formulation services, and pharmacovigilance. The market value includes the value of related goods sold by the service provider or included within the service offering. The tardive dyskinesia therapeutics market also includes sales of adjunctive medications, patient monitoring devices, drug delivery systems, and screening tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tardive Dyskinesia Therapeutics Market Report 2026?

The tardive dyskinesia therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Tardive Dyskinesia Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.35 billion
Revenue Forecast In 2035	$4.39 billion
Growth Rate	CAGR of 7.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug, Product Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Neurocrine Biosciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation, AbbVie Inc., Pfizer Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Tardive Dyskinesia Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Tardive Dyskinesia Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Tardive Dyskinesia Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Tardive Dyskinesia Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Deutetrabenazine And Valbenazine

4.2.2 Increased Focus On Personalized Neurological Therapy

4.2.3 Expansion Of Homecare And Remote Treatment Options

4.2.4 Growing Awareness About Drug-Induced Tardive Dyskinesia

4.2.5 Emphasis On Safety And Compliance In Long-Term Treatment

5. Tardive Dyskinesia Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Specialty Treatment Centers

5.4 Homecare Settings

5.5 Neurology Research Institutions

6. Tardive Dyskinesia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tardive Dyskinesia Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tardive Dyskinesia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Tardive Dyskinesia Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Tardive Dyskinesia Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Tardive Dyskinesia Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tardive Dyskinesia Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tardive Dyskinesia Therapeutics Market Segmentation

9.1. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deutetrabenazine, Valbenazine, Other Drugs

9.2. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solid Dosage Forms, Tablets, Capsules, Liquid Dosage Form

9.3. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antipsychotic-Induced Tardive Dyskinesia, Other Drug-Induced Tardive Dyskinesia, Idiopathic Tardive Dyskinesia

9.4. Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Specialty Treatment Centers, Homecare Settings

9.5. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dosage Forms, Line Of Therapy, Distribution Channel

9.6. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dosage Forms, Patient Age Group, Distribution Channel

9.7. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Class Or Type, Dosage Forms, Treatment Duration

10. Tardive Dyskinesia Therapeutics Market Regional And Country Analysis

10.1. Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tardive Dyskinesia Therapeutics Market

11.1. Asia-Pacific Tardive Dyskinesia Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tardive Dyskinesia Therapeutics Market

12.1. China Tardive Dyskinesia Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tardive Dyskinesia Therapeutics Market

13.1. India Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tardive Dyskinesia Therapeutics Market

14.1. Japan Tardive Dyskinesia Therapeutics Market Overview

14.2. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tardive Dyskinesia Therapeutics Market

15.1. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tardive Dyskinesia Therapeutics Market

16.1. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tardive Dyskinesia Therapeutics Market

17.1. South Korea Tardive Dyskinesia Therapeutics Market Overview

17.2. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tardive Dyskinesia Therapeutics Market

18.1. Taiwan Tardive Dyskinesia Therapeutics Market Overview

18.2. Taiwan Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tardive Dyskinesia Therapeutics Market

19.1. South East Asia Tardive Dyskinesia Therapeutics Market Overview

19.2. South East Asia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tardive Dyskinesia Therapeutics Market

20.1. Western Europe Tardive Dyskinesia Therapeutics Market Overview

20.2. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tardive Dyskinesia Therapeutics Market

21.1. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tardive Dyskinesia Therapeutics Market

22.1. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tardive Dyskinesia Therapeutics Market

23.1. France Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tardive Dyskinesia Therapeutics Market

24.1. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tardive Dyskinesia Therapeutics Market

25.1. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tardive Dyskinesia Therapeutics Market

26.1. Eastern Europe Tardive Dyskinesia Therapeutics Market Overview

26.2. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tardive Dyskinesia Therapeutics Market

27.1. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tardive Dyskinesia Therapeutics Market

28.1. North America Tardive Dyskinesia Therapeutics Market Overview

28.2. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tardive Dyskinesia Therapeutics Market

29.1. USA Tardive Dyskinesia Therapeutics Market Overview

29.2. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tardive Dyskinesia Therapeutics Market

30.1. Canada Tardive Dyskinesia Therapeutics Market Overview

30.2. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tardive Dyskinesia Therapeutics Market

31.1. South America Tardive Dyskinesia Therapeutics Market Overview

31.2. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tardive Dyskinesia Therapeutics Market

32.1. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tardive Dyskinesia Therapeutics Market

33.1. Middle East Tardive Dyskinesia Therapeutics Market Overview

33.2. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tardive Dyskinesia Therapeutics Market

34.1. Africa Tardive Dyskinesia Therapeutics Market Overview

34.2. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tardive Dyskinesia Therapeutics Market Regulatory and Investment Landscape

36. Tardive Dyskinesia Therapeutics Market Competitive Landscape And Company Profiles

36.1. Tardive Dyskinesia Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Tardive Dyskinesia Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Tardive Dyskinesia Therapeutics Market Company Profiles

36.3.1. Neurocrine Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Lundbeck A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Mitsubishi Tanabe Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tardive Dyskinesia Therapeutics Market Other Major And Innovative Companies

AbbVie Inc., Pfizer Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Ltd., Lupin Limited, Amneal Pharmaceuticals Inc., Lannett Company Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Accord Healthcare Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd.

38. Global Tardive Dyskinesia Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tardive Dyskinesia Therapeutics Market

40. Tardive Dyskinesia Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Tardive Dyskinesia Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Tardive Dyskinesia Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Tardive Dyskinesia Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Tardive Dyskinesia Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Tardive Dyskinesia Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Tardive Dyskinesia Therapeutics Market, Supply Chain Analysis

Table 4: Global Tardive Dyskinesia Therapeutics Market, Major Raw Material Providers

Table 5: Global Tardive Dyskinesia Therapeutics Market, Major Resource Providers

Table 6: Global Tardive Dyskinesia Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Tardive Dyskinesia Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Tardive Dyskinesia Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Tardive Dyskinesia Therapeutics Market, Major Trends

Table 10: Global Tardive Dyskinesia Therapeutics Market, Major End Users

Table 11: Global Tardive Dyskinesia Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Tardive Dyskinesia Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Tardive Dyskinesia Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Tardive Dyskinesia Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Tardive Dyskinesia Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Tardive Dyskinesia Therapeutics Market - Company Scoring Matrix

Table 98: Neurocrine Biosciences Inc. Financial Performance

Table 99: Teva Pharmaceutical Industries Ltd. Financial Performance

Table 100: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Table 101: Lundbeck A/S Financial Performance

Table 102: Mitsubishi Tanabe Pharma Corporation Financial Performance

Table 103: Global Tardive Dyskinesia Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Tardive Dyskinesia Therapeutics Market, Competitive Dashboard

Table 105: Global Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Table 107: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 108: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Tardive Dyskinesia Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Tardive Dyskinesia Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Tardive Dyskinesia Therapeutics Market, Supply Chain Analysis

Figure 4: Global Tardive Dyskinesia Therapeutics Market, Major Raw Material Providers

Figure 5: Global Tardive Dyskinesia Therapeutics Market, Major Resource Providers

Figure 6: Global Tardive Dyskinesia Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Tardive Dyskinesia Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Tardive Dyskinesia Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Tardive Dyskinesia Therapeutics Market, Major Trends

Figure 10: Global Tardive Dyskinesia Therapeutics Market, Major End Users

Figure 11: Global Tardive Dyskinesia Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Tardive Dyskinesia Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Tardive Dyskinesia Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Tardive Dyskinesia Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Tardive Dyskinesia Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Tardive Dyskinesia Therapeutics Market - Company Scoring Matrix

Figure 98: Neurocrine Biosciences Inc. Financial Performance

Figure 99: Teva Pharmaceutical Industries Ltd. Financial Performance

Figure 100: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Figure 101: Lundbeck A/S Financial Performance

Figure 102: Mitsubishi Tanabe Pharma Corporation Financial Performance

Figure 103: Global Tardive Dyskinesia Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Tardive Dyskinesia Therapeutics Market, Competitive Dashboard

Figure 105: Global Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Figure 107: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 108: Global, Tardive Dyskinesia Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Bipolar Disorder Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Seroton...

Peptide Therapeutics Market Report 2026 - Global Outlook – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal ), By Application (Cancer, Cardiovascular Diseases, Central Nervou...

Liver Diseases Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment (Antiviral, Chemotherapy, Immunosuppressive A...

Cystic Fibrosis (CF) Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment...

Plasma Protein Therapeutics Market Report 2026 - Global Outlook – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), ...

Post-Traumatic Stress Disorder Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, ...

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2026 - Global Outlook – By Drug Type (Antiarrhythmic Agents, Anticoagulants, Beta Adrenergic Blocking Agents, Calcium Channel Blockers, Other Drug Types), By D...

Frequently Asked Questions

How big is the Tardive Dyskinesia Therapeutics Market?

The Tardive Dyskinesia Therapeutics market was valued at $3.12 billion in 2025, increased to $3.35 billion in 2026, and is projected to reach $4.39 billion by 2030.

What is the Tardive Dyskinesia Therapeutics market growth?

The global Tardive Dyskinesia Therapeutics market is expected to grow at a CAGR of 7.0% from 2026 to 2035 to reach $4.39 billion by 2035.

Who are the key players in Tardive Dyskinesia Therapeutics market?

Some Key Players in the Tardive Dyskinesia Therapeutics market Include, Neurocrine Biosciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation, AbbVie Inc., Pfizer Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Ltd., Lupin Limited, Amneal Pharmaceuticals Inc., Lannett Company Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Accord Healthcare Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Indivior PLC, Viatris Inc., Alkem Laboratories Ltd., Intas Pharmaceuticals Ltd., Som Biotech Ltd., Addex Therapeutics Ltd., Luye Pharma Group Ltd., Apotex Inc., Sandoz Group AG, Torrent Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Taro Pharmaceutical Industries Ltd., Cadila Pharmaceuticals Ltd. .

What is the anticipated growth trend for the Tardive Dyskinesia Therapeutics market?

Major trend in this market includes: Advancements In Once-Daily Treatment Options Enhancing Consistent Drug Delivery And Patient Compliance. For further insights on this market. request a sample here

Which region has the most growth potential in the Tardive Dyskinesia Therapeutics market?

North America was the largest region in the tardive dyskinesia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.